Biliary candida infections in primary sclerosing cholangitis
- PMID: 16979779
- DOI: 10.1016/j.jhep.2006.07.022
Biliary candida infections in primary sclerosing cholangitis
Abstract
Background/aims: Patients with Primary Sclerosing Cholangitis (PSC) frequently develop dominant stenoses of the bile ducts and bacterial infections represent a major problem in such patients. In the present study, the role of fungal infections of the bile ducts has been evaluated.
Methods: In a prospective non-randomized trial, in 67 consecutive patients with PSC, 148 bile samples, each taken at one endoscopic examination, were microbiologically analysed.
Results: Candida species were found in 8/67 patients whereas Aspergillus was not detected. Seven patients with biliary Candida had a dominant stenosis and one had a wide papillotomy with chronic ascending cholangitis. Altogether 7/49 of patients with dominant stenosis and 1/18 of patients without dominant stenosis had Candida in their bile. All patients with biliary Candida intermittently had received antibiotics and had advanced disease with cholestasis. Candida disappeared spontaneously in 2/7 patients, cleared after antifungal treatment in 2, and persisted in 3 patients. Patients with biliary Candida had more severe cholangitis with higher CRP and serum bilirubin compared to those without Candida infection.
Conclusions: This is the first report on the identification of Candida species in the bile of patients with PSC. Apart from bacterial also fungal infection of the bile ducts should be considered in the treatment of such patients.
Similar articles
-
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.J Hepatol. 2009 Jul;51(1):149-55. doi: 10.1016/j.jhep.2009.01.023. Epub 2009 Mar 27. J Hepatol. 2009. PMID: 19410324
-
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.Endoscopy. 2006 Jul;38(7):665-9. doi: 10.1055/s-2006-925257. Epub 2006 Apr 27. Endoscopy. 2006. PMID: 16673310
-
Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.Aliment Pharmacol Ther. 2014 Apr;39(8):873-82. doi: 10.1111/apt.12663. Epub 2014 Feb 24. Aliment Pharmacol Ther. 2014. PMID: 24612312
-
Primary sclerosing cholangitis: the role of endoscopic therapy.Semin Liver Dis. 2006 Feb;26(1):62-8. doi: 10.1055/s-2006-933564. Semin Liver Dis. 2006. PMID: 16496234 Review.
-
Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.Clin Liver Dis. 2010 May;14(2):349-58. doi: 10.1016/j.cld.2010.03.010. Clin Liver Dis. 2010. PMID: 20682240 Review.
Cited by
-
Approach to a patient with elevated serum alkaline phosphatase.Clin Liver Dis. 2012 May;16(2):199-229. doi: 10.1016/j.cld.2012.03.012. Epub 2012 Apr 6. Clin Liver Dis. 2012. PMID: 22541695 Free PMC article. Review.
-
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.Gut. 2019 Aug;68(8):1356-1378. doi: 10.1136/gutjnl-2018-317993. Epub 2019 Jun 1. Gut. 2019. PMID: 31154395 Free PMC article.
-
Role of the Gut-Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence.Int J Mol Sci. 2023 Apr 3;24(7):6660. doi: 10.3390/ijms24076660. Int J Mol Sci. 2023. PMID: 37047635 Free PMC article. Review.
-
Treatment of primary sclerosing cholangitis.Curr Treat Options Gastroenterol. 2007 Apr;10(2):111-9. doi: 10.1007/s11938-007-0063-6. Curr Treat Options Gastroenterol. 2007. PMID: 17391626
-
Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.World J Gastroenterol. 2014 Sep 14;20(34):12260-8. doi: 10.3748/wjg.v20.i34.12260. World J Gastroenterol. 2014. PMID: 25232260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous